MYLAN 217 250 (Tolazamide 250 mg)
Pill imprint MYLAN 217 250 has been identified as Tolazamide 250 mg.
Tolazamide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Tolazamide 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
Tolazamide
- Imprint:
- MYLAN 217 250
- Strength:
- 250 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0217
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0556 | Amerisource Health Services |
Note: Inactive ingredients may vary.
More about tolazamide
Consumer resources
- Other brands: Tolinase
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
